Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

KI-forskare har upptäckt biomarkörer för postcovid

Forskare vid Karolinska institutet har i en ny studie identifierat en uppsättning proteiner i blod hos personer med långvariga besvär av postcovid.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

An easy way to handle microtiter plate stacks

Do you want to automate handling of microtiter plates.? Have a look at a very simple solution on how to handle them.

RegFile AB

Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

ZEISS Quality Innovations at CONTROL

May 6-9, 2025 in Stuttgart.

Mercodia AB

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Explore our tailored program for Control 2025

Choose an innovation tour, or join our industry-specific guided tours.

Non-destructive testing and assembly control

Assess complete assembly.

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...

AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence

AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.

Speed meets precision for high-density components

ZEISS METROTOM 800 320 kV.

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7.

Lonza

ProPharma

SGS Fimko Ltd.

Fundamental Aspects of Airy Disk Patterns

Knowledge Article from ZEISS.

Anna Törner: Vem betalar för Rebecca Doe – och alla oss andra?

Det lätt att vänja sig vid tanken att vård och läkemedel är gratis, när det egentligen handlar om hur och vem som betalar. Det skriver Anna Törner i en krönika.

Hon är ny vd för CSL Behring

Helena Bragd är sedan början på januari ny Nordic General Manager för biotechbolaget CSL Behring samt vd för CSL Behring AB.

QPS Netherlands B.V

Trump in new push to lower drug prices

U.S. President Donald Trump announced on Sunday that he plans to sign an executive order to lower the cost of prescription drugs to the same levels paid in othe...